Evidence map›Paper›PMID 37886670›Full record

ArticleFrontiers in digital health2023

Involving trained community health mediators in COVID-19 prevention measures. A process evaluation from Bremen, Germany.

Tilman Brand, Marieke Gerstmann, Florence Samkange-Zeeb, Hajo Zeeb

Open access · goldAbstract read
In one paragraph

Article in Frontiers in digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tilman BrandDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology (LG), Bremen, Germany.
Marieke GerstmannDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology (LG), Bremen, Germany.
Florence Samkange-ZeebDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology (LG), Bremen, Germany.
Hajo ZeebDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology (LG), Bremen, Germany.
Leibniz Institute for Prevention Research and Epidemiology - BIPS · DEUniversity of Bremen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The objective was to assess the feasibility of incorporating trained community health mediators in COVID-19 prevention in a multicultural and disadvantaged setting in Bremen, Germany. Specifically, we aimed to develop and implement measures corresponding to the needs of the residents and to analyse the role of digital communication tools and sustainability factors of the health mediator approach. Methods: A comprehensive process evaluation using 41 qualitative interviews with residents, mediator short surveys and group discussions, work documentation sheets, and a stakeholder workshop was carried out. Results: Uncertainties due to changing regulations, a lack of trust and fear of potential side effects were major themes identified in the needs assessment. The eight mediators documented more than 1,600 contacts. Digital communication via Facebook was a useful tool, but personal contacts remained crucial for communicating with residents. The participatory approach, multilingualism and the flexibility to react to dynamic situations were identified as relevant factors for the success and sustainability of the health mediator approach. Conclusion: Multilingual health mediators can facilitate contact with and dissemination of health information to different communities and also can play an important role in pandemic preparedness.

Indexed as

COVID-19health mediatorsmigrationparticipationprocess evaluation

Identifiers

PMID37886670
PMCPMC10598750
OpenAlexW4387532890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.